Reuters logo
BRIEF-Innate Pharma H1 operating loss widens to 18.2 million euros
September 18, 2017 / 5:08 AM / a month ago

BRIEF-Innate Pharma H1 operating loss widens to 18.2 million euros

Sept 18 (Reuters) - INNATE PHARMA SA:

* ‍CASH, CASH EQUIVALENTS AND FINANCIAL ASSETS() FOR COMPANY AMOUNTED TO EUR 204.1M (MILLION EUROS) AS OF JUNE 30, 2017​

* ‍A NET LOSS FOR FIRST HALF OF 2017 AMOUNTING TO EUR 23.4M (EUR 3.2M FOR FIRST HALF OF 2016).​

* H1 REVENUE EUR 21.3 MILLION VERSUS EUR 20.7 MILLION YEAR AGO

* H1 OPERATING LOSS EUR 18.2 MILLION VERSUS LOSS OF EUR 2.9 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below